Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Depression and Health Outcomes in Refractory Epilepsy Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified health advice, visits or treatment with a real mD. We are not doctors. Always consult your doctor about Depression and Health Outcomes in Refractory Epilepsy conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Depression and Health Outcomes in Refractory Epilepsy Clinical research trials and Depression and Health Outcomes in Refractory Epilepsy healthcare trials happen in many of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new drugs. The purpose of the studies / projects is to solve particular human medical questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to discover cures for all varieties of conditions, such as Depression and Health Outcomes in Refractory Epilepsy. Depression and Health Outcomes in Refractory Epilepsy Clinical Trials and other clinical trials allow volunteers to have health treatment alternatives before they are available to the masses. Some times the human subjects obtain treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Depression and Health Outcomes in Refractory Epilepsy clinical trial. Test subjects oftentimes receive the most effective healthcare possible for their Depression and Health Outcomes in Refractory Epilepsy condition. Dangers are a reality, however, and may include extra or frequent physician visits, healthcare dangers (possibly life-jeopardising), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials patients.

Home > "D" Clinical Trials Conditions > Depression and Health Outcomes in Refractory Epilepsy

Depression and Health Outcomes in Refractory Epilepsy



Depression and Health Outcomes in Refractory Epilepsy

For Condition: Epilepsy,Depression
Status: Recruiting
Sponsor(s): National Institute of Neurological Disorders and Stroke (NINDS) ,
Synopsis: To define the benefits of antidepressant treatment or cognitive behavior therapy on mood, function, and quality of life in patients with depression and refractory epilepsy.
Details: This randomized clinical trial will be conducted to compare the drug sertraline to cognitive behavioral therapy on symptoms of depression, antiepileptic medication compliance, seizure frequency, and quality of life outcomes in patients with depression and a seizure disorder or epilepsy. Approximately 254 patients will be enrolled in this study over a period of five years. Individual participation will last approximately 16 weeks. Study participants will be chosen randomly to receive either the study medication (sertraline) or cognitive behavior therapy for 16 weeks. Sertraline is approved by the Food and Drug Administration (FDA). Subjects who receive cognitive behavior therapy will be provided with a one-hour individual session with a licensed clinical psychologist each week for 15 weeks. All study participants will attend scheduled clinic visits every 4 weeks for 16 weeks.
Eligibility:
Study Type:  Interventional, Randomized
Minimum Age/Maximum Age: 21 Years/75 Years
Genders: Both
Protocol Entry Criteria: INCLUSION: - Must have a seizure disorder. - Must meet the DSM-IV criteria for major depression. - Must be willing to provide written informed consent. - Must be age 21 to 75 years old. - Must be compliant, cooperative, reliable, and able to follow instructions, and to visit the clinic on schedule. EXCLUSION: - Have active suicidal or homicidal ideation. - Have current alcohol or other substance abuse disorders or a history of bipolar depression or any psychotic disorder. - Are pregnant or lactating. - Are known to be hypersensitive to sertraline. - Have a progressive central nervous system disorder (such as a tumor or multiple sclerosis), or severe hepatic or renal disease (serum creatinine >3 mg/dl).
Total Enrollment: 254

Location and Contact Information:

Overall Study Official:
FrankGilliam,  Principal Investigator,  Washington University School of Medicine

Washington University School of Medicine *Recruiting*
St. Louis,  Missouri, 
United States
Recruiting Tori  Vahle 314-362-7845


Additional Information:
Study ID Numbers:  R01NS4080; 
Study Start Date: August 2001
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00026637

Other Depression Studies:
1. Evaluation and Treatment of Patients with Epilepsy

2. Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy.

3. Non-Invasive Seizure Localization in Patients with Medically Refractory Localization Related Epilepsy: Synchronized MEG-EEG Recordings

4. Multicenter trial for adults with partial seizures

5. Search for Genes Influencing Childhood Absence Epilepsy Study

Related Studies:

Other Depression Clinical Trials
Other Missouri Clinical Trials
Other St. Louis Clinical Trials

Depression and Health Outcomes in Refractory Epilepsy
Modify your Search

  Other Depression Clinical Trials
  Other Missouri Clinical Trials
  Other St. Louis Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103